NGF and brain ischemia: In another preclinical experiment of cerebral ischemia, the researchers designed an exosome with RVG peptides on the surface to target neurons and loaded nerve growth factor (NGF), which showed that the surface-modified exosomes maintain high NGF stability, thereby prolonging the time that they remain effective in the body [126].